| GTO ID | GTC1791 |
| Trial ID | NCT03294954 |
| Disease | Neuroblastoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | GD2 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma |
| Year | 2018 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-41033 GINAKIT2 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||